The results of IHC staining also indicated that PLCG2 expression was higher in NSCLC tissues (Fig. 4E) and its level was related to the prognosis of NSCLC patients in the TCGA cohort (Fig. 4F). The gene discussed is PLCG2; the disease is non-small cell lung carcinoma.